Stockigt Jim
Department of Endocrinology and Diabetes, Monash University Department of Medicine, Alfred Hospital, Prahran, VIC, Australia.
Clin Biochem Rev. 2003 Nov;24(4):109-22.
Laboratory assessment of thyroid function is now often initiated with a low pre-test probability, by clinicians who may not have a detailed knowledge of current methodology or testing strategies. Skilled laboratory staff can significantly enhance the choice of appropriate tests and the accuracy of clinical response; such involvement requires both appropriate training and relevant information from the clinician. Measurement of the serum thyroid stimulating hormone (TSH) concentration with an assay of adequate sensitivity is now the cornerstone of thyroid function testing; for untreated populations at risk of primary thyroid dysfunction, a normal TSH concentration rules out an abnormality with a high degree of certainty. However, in several important situations, most notably pituitary abnormalities and early treatment of thyroid dysfunction, serum TSH can give a misleading indication of thyroid status. An abnormal TSH concentration alone is never an adequate basis for initiation of treatment, which should be based on the typical relationship between trophic and target gland hormones, based on serum TSH and an estimate of serum free thyroxine (T4). Six basic assumptions, some clinical, some laboratory-based, need to be considered, together with the relevant limiting conditions, for reliable use of this relationship. Current methods of free T4 estimation remain imperfect, especially during critical illness. Diagnostic approach differs significantly between initial diagnosis and follow-up of treated thyroid dysfunction. In some situations, serum triiodothyronine (T3) is also required, but serum T3 lacks sensitivity for diagnosis of hypothyroidism, and has poor specificity during non-thyroidal illness. Where assay results are anomalous, most atypical findings can be resolved by attention to the clinical context, without further investigation.
甲状腺功能的实验室评估如今常常在临床医生对当前方法或检测策略缺乏详细了解、预测试概率较低的情况下启动。熟练的实验室工作人员能够显著提升合适检测项目的选择以及临床反应的准确性;这种参与既需要适当的培训,也需要临床医生提供相关信息。采用具有足够灵敏度的检测方法测量血清促甲状腺激素(TSH)浓度,如今是甲状腺功能检测的基石;对于有原发性甲状腺功能障碍风险的未治疗人群,TSH浓度正常可高度确定地排除异常情况。然而,在一些重要情形下,最显著的是垂体异常和甲状腺功能障碍的早期治疗中,血清TSH可能会对甲状腺状态给出误导性指示。仅TSH浓度异常绝不是开始治疗的充分依据,治疗应基于促甲状腺激素与靶腺激素之间的典型关系,依据血清TSH以及血清游离甲状腺素(T4)的估计值来进行。为了可靠地利用这种关系,需要考虑六个基本假设,有些是临床方面的,有些是基于实验室的,同时还要考虑相关的限制条件。目前游离T4的估计方法仍不完善,尤其是在危重病期间。甲状腺功能障碍初始诊断和治疗后随访的诊断方法有显著差异。在某些情况下,也需要检测血清三碘甲状腺原氨酸(T3),但血清T3对甲状腺功能减退症的诊断缺乏敏感性,在非甲状腺疾病期间特异性也较差。当检测结果异常时,大多数非典型发现通过关注临床背景即可解决,无需进一步调查。